DIVI S LABORATORIES LTD vs NEULAND LAB LTD.

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and NEULAND LAB LTD. (NEULANDLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs NEULANDLAB on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
64.97
10.72
P/B ratio
13.37
0.44%
Dividend yield
0.17%
₹96.73
EPS
₹283.71

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
21.40%
22.00%
Return on capital
27.00%
33.00%
EBITDA margin
28.00%
24.32%
Net margin
17.99%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
19.31%
12.10%
Profit CAGR (3Y)
30.44%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹23,643 Cr
₹10,560 Cr
Revenue
₹2,023 Cr
₹2,568 Cr
Net profit
₹364 Cr
0.00
Debt / equity
0.16
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
NEULAND LAB LTD.
  • + ["Company is expected to give good quarter", "Company has delivered good profit growth of 38.5% CAGR over last 5 years"]
  • ["Stock is trading at 13.4 times its book value", "Promoter holding has decreased over last 3 years: -3.50%"]
DIVI S LABORATORIES LTD full analysis NEULAND LAB LTD. full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVI S LABORATORIES LTD vs NEULAND LAB LTD.: Share Price, Valuation & Which to Buy | DocStoX